In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

Experts discuss South Africa’s current vaccine manufacturing capabilities and the steps needed to prepare for future ...

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...

Background Increased pigmentation has been associated with cancer stem-cell-like behaviour and chemoresistance in uveal ...